Expression of mTOR in Primary Pterygium and its Correlation with α-Smooth Muscle Actin

Xin-Rong Zhao1,2, Ming-Chang Zhang1, Hua-Tao Xie1

  • 11 Department of Ophthalmology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan - China.

Abstract

Insights

Mammalian target of rapamycin (mTOR) is elevated in pterygium tissues, correlating positively with alpha-smooth muscle actin (α-SMA). This suggests mTOR may play a role in pterygium development.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Cell Biology

Background:

  • Mammalian target of rapamycin (mTOR) regulates critical cellular functions including growth and metabolism.
  • Expression of mTOR in pterygium, a proliferative ocular condition, remains under-investigated.
  • Alpha-smooth muscle actin (α-SMA) serves as a key marker for fibroblast transdifferentiation.

Purpose of the Study:

  • To investigate the expression of mTOR in pterygium tissues.
  • To determine the correlation between mTOR levels and α-SMA expression in pterygium.

Main Methods:

  • Surgical excision and analysis of 28 primary pterygium and 16 normal conjunctival samples.
  • Immunohistochemistry and Western blotting were employed to assess mTOR and α-SMA expression.
  • Statistical analysis was performed to evaluate correlations between mTOR and α-SMA levels.

Main Results:

  • Significantly higher expression of both mTOR and α-SMA was observed in pterygium tissues compared to normal conjunctiva.
  • A significant positive correlation was found between mTOR-immunopositive fibroblasts and α-SMA-immunopositive fibroblasts (ρ = 0.463, p = 0.0078).
  • mTOR expression showed a significant positive correlation with α-SMA expression in pterygium (ρ = 0.269, p = 0.031).

Conclusions:

  • Pterygium tissues exhibit increased mTOR expression relative to normal conjunctiva.
  • The positive correlation between mTOR and α-SMA suggests a potential role in pterygium pathogenesis.
  • These findings highlight mTOR as a potential therapeutic target in pterygium.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K